Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
WASHINGTON HOTEL, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 31%, Dividend Revised Upward by 14 Yen
4691 WASHINGTON HOTEL CORPORATION 【J-GAAP】
Earnings ReportWASHINGTON HOTEL CORPORATION <4691> [TSE Std] announced its financial results after the market closed on February 12th (15:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded 3.13 billion yen, an increase 83.5% compared to the same period last year.
In addition, the full-year forecast for ordinary profit has been revised upward 30.9%, from the previous forecast of 2.46 billion yen to 3.22 billion yen (compared to 1.75 billion yen in the previous period), increasing the growth rate from 40.2% to 83.5%.
Based on the full-year plan announced by the company after the upward revision, our estimate of the ordinary profit for the October to March period (second half) is expected to increase 2.0 times, from the previous forecast of 0.73 billion yen to 1.49 billion yen (compared to 1.11 billion yen in the same period of the previous year), turning to a 34.6% increase in the ordinary profit outlook.
In light of the strong performance, the company has significantly increased its planned year-end lump-sum dividend for the current fiscal year from the original plan of 26 yen to 40 yen (compared to 20 yen in the previous period).
In the most recent three-month period, from October to December (3Q), the ordinary profit increased 32.5% from the same period last year, reaching 1.41 billion yen. The operating profit margin rose from 19.3% in the same period last year to 22.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 13,994 | 1,436 | 1,135 | 1,103 | 91.5 | 121.1 | Feb 14, 2024 | J-GAAP |
| Apr - Dec, 2024 | 16,322 | 2,055 | 1,710 | 1,710 | 141.8 | 97.4 | Feb 14, 2025 | J-GAAP |
| Apr - Dec, 2025 | 18,959 | 3,553 | 3,137 | 3,108 | 258.8 | 97.4 | Feb 12, 2026 | J-GAAP |
| YoY | +16.2% | +72.9% | +83.5% | +81.8% | +82.5% |
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2025 Prev | 11,443 | 1,048 | 739 | 717 | 59.8 | 26 | Nov 14, 2025 | J-GAAP |
| Oct - Mar, 2025 New | 12,143 | 1,758 | 1,499 | 1,227 | 102.3 | 40 | Feb 12, 2026 | J-GAAP |
| Revision Rate | +6.1% | +67.7% | +102.8% | +71.1% | +71.1% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 23,500 | 3,050 | 2,460 | 2,420 | 201.8 | 26 | Aug 14, 2025 | J-GAAP |
| Mar, 2026 New | 24,200 | 3,760 | 3,220 | 2,930 | 244.3 | 40 | Feb 12, 2026 | J-GAAP |
| Revision Rate | +3.0% | +23.3% | +30.9% | +21.1% | +21.1% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 11,218 | 1,381 | 1,114 | 1,274 | 105.7 | 20 | May 14, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 12,143 | 1,758 | 1,499 | 1,227 | 102.3 | 40 | Feb 12, 2026 | J-GAAP |
| YoY | +8.2% | +27.3% | +34.6% | -3.7% | -3.2% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 18,294 | 1,490 | 937 | 835 | 69.3 | 10 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 21,347 | 2,240 | 1,755 | 2,015 | 167.1 | 20 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 24,200 | 3,760 | 3,220 | 2,930 | 244.3 | 40 | Feb 12, 2026 | J-GAAP |
| YoY | +13.4% | +67.9% | +83.5% | +45.4% | +46.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 6,193 | 1,196 | 1,069 | 969 | 80.4 | 19.3 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 5,025 | 185 | 45 | 305 | 25.3 | 3.7 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 6,049 | 1,043 | 892 | 883 | 73.5 | 17.2 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 6,008 | 959 | 829 | 820 | 68.2 | 16.0 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 6,902 | 1,551 | 1,416 | 1,405 | 117.0 | 22.5 | Feb 12, 2026 | J-GAAP |
| YoY | +11.4% | +29.7% | +32.5% | +45.0% | +45.6% |
Related Articles
PBsystems, Oct-Dec (1Q) Ordinary Profit Decreases by 89%
INPEX, 16% Decrease in Net Income for The Current Fiscal Year, Dividend Raised by 8 Yen
KLab, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
en Japan, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 12%, Exceeds Full-Year Plan
Fuso Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 34%, Oct-Dec Ordinary Profit Decreases by 9%
SD ENTERTAINMENT, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Turns to Loss
CyberBuzz, Oct-Dec (1Q) Ordinary Profit Increases by 50%
ReproCELL, Ordinary Profit Forecast for the Fiscal Year Loss Widened in Downward Revision
Monex Group, Apr-Dec (Cumulative 3Q) Net Income Turns to Profit, Oct-Dec Net Income Turns to Profit
ROHTO PHARMA, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Exceeded Record Profit Forecast, Dividend Revised Upward by 1 Yen